These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6716260)

  • 21. [Pharmacokinetics of lidocaine after intravenous and oral administration in patients with liver cirrhosis].
    Fuchshofen M; Zilly W; Epping J; Richter E
    Verh Dtsch Ges Inn Med; 1978; (84):1110-2. PubMed ID: 741898
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination.
    Saville BA; Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):17-21. PubMed ID: 2881753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver.
    Vu VT; Chen CP
    Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 26. First-pass metabolism of lidocaine in the anesthetized rabbit. Contribution of the small intestine.
    Lê KT; Maurice H; du Souich P
    Drug Metab Dispos; 1996 Jul; 24(7):711-6. PubMed ID: 8818566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.
    Benowitz N; Forsyth FP; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1974 Jul; 16(1):87-98. PubMed ID: 4210516
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.
    Tucker GT; Bax ND; Lennard MS; Al-Asady S; Bharaj HS; Woods HF
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):21S-28S. PubMed ID: 6146336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of melatonin in man: first pass hepatic metabolism.
    Lane EA; Moss HB
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1214-6. PubMed ID: 4055987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man.
    Stenson RE; Constantino RT; Harrison DC
    Circulation; 1971 Feb; 43(2):205-11. PubMed ID: 5540706
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
    Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H
    Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of epilepsy in the light of the determination of the anticonvulsant blood level].
    Majkowski J
    Neurol Neurochir Pol; 1971; 5(3):295-300. PubMed ID: 5116780
    [No Abstract]   [Full Text] [Related]  

  • 34. Biological determinants of altered pharmacokinetics in the elderly.
    Shand DG
    Gerontology; 1982; 28 Suppl 1():8-17. PubMed ID: 7044905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic first-pass metabolism in liver disease.
    Blaschke TF; Rubin PC
    Clin Pharmacokinet; 1979; 4(6):423-32. PubMed ID: 391462
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduced felodipine bioavailability in patients taking anticonvulsants.
    Capewell S; Freestone S; Critchley JA; Pottage A; Prescott LF
    Lancet; 1988 Aug; 2(8609):480-2. PubMed ID: 2900404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining hepatic transport kinetics by mathematical modeling.
    Luxon BA; Forker EL
    Fed Proc; 1984 Feb; 43(2):161-3. PubMed ID: 6692934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect.
    Bae SK; Yang KH; Aryal DK; Kim YG; Lee MG
    J Pharm Sci; 2009 Apr; 98(4):1587-601. PubMed ID: 18780336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
    J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolite Kinetics: The Segregated Flow Model for Intestinal and Whole Body Physiologically Based Pharmacokinetic Modeling to Describe Intestinal and Hepatic Glucuronidation of Morphine in Rats In Vivo.
    Yang QJ; Fan J; Chen S; Liu L; Sun H; Pang KS
    Drug Metab Dispos; 2016 Jul; 44(7):1123-38. PubMed ID: 27098743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.